Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR Acinetobacter baumannii: In silico, in vitro and in vivo Studies

PURPOSE: Acinetobacter baumannii antibiotic resistant infections in high-risk patients are a great challenge for researchers and clinicians worldwide. In an effort to achieve potent bactericidal outcomes, a novel chitosan–mastoparan nanoconstruct (Mast-Cs NC) was designed and assessed for its therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Afreenish, Ikram, Aamer, Raza, Abida, Saeed, Sidra, Zafar Paracha, Rehan, Younas, Zumara, Khadim, Muhammad Tahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179793/
https://www.ncbi.nlm.nih.gov/pubmed/34103914
http://dx.doi.org/10.2147/IJN.S296717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179793/
https://www.ncbi.nlm.nih.gov/pubmed/34103914
http://dx.doi.org/10.2147/IJN.S296717

Ejemplares similares